KCK Ltd.
- SEC CIK
- 0001657662
- Latest filing
- Oct 14, 2025
Holdings changes from Q4 2024 to Q1 2025
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 0
- Added
- 0
- Reduced
- 0
- Sold out
- 1
- Est. −$59.0M
Portfolio value went from $75.0M to $10.5M (−$64.4M (−85.9%)); positions from 3 to 2 (−1).
All Q1 2025 holdingsAll Q4 2024 holdings
In the shares, value and % of portfolio columns, the top figure is Q1 2025 and the gray one below is Q4 2024. For stocks that split between the two quarters, Q4 2024 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| SGHTSight Sciences, Inc. | UnchangedHistory | 4,374,9754,374,975 | 00.0% | $10.5M$15.9M | $0 | 99.6%21.2% | +78.38 |
| RNTXRein Therapeutics, Inc. | UnchangedHistory | 22,34122,341 | 00.0% | $39.5K$51.4K | $0 | 0.4%0.1% | +0.31 |
| NPCENeuroPace Inc | Sold outHistory | 05,270,845 | −5,270,845−100.0% | $0$59.0M | −$59.0M | 0.0%78.7% | −78.69 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.